FCH
PFE icon

Freestone Capital Holdings’s Pfizer PFE Stock Holding History

Freestone Capital Holdings’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-14,229
Closed -$388K – 364
2013
Q3 		$388K Buy
+14,229
New +$387K 0.07% 253

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Freestone Capital Holdings's PFE Position: Q1 2026 in Review

Freestone Capital Holdings increased its Pfizer (PFE) stake by 1.5% in Q1 2026, buying an estimated $20.2K and bringing the position to 49,665 shares worth $1.39M. The position accounts for 0.04% of the portfolio, ranked #212.

Freestone Capital Holdings first reported a position in PFE in Q3 2013 and has held it in 47 quarters since. The position peaked at $9.54M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Freestone Capital Holdings held 49,665 shares of Pfizer worth $1.39M as of Q1 2026.
  • Freestone Capital Holdings bought 758 Pfizer shares in Q1 2026, an estimated $20.2K.
  • Pfizer made up 0.04% of Freestone Capital Holdings's portfolio in Q1 2026, its #212 holding.
  • Freestone Capital Holdings first reported a position in Pfizer in Q3 2013 and has held it in 47 quarters since.
  • Freestone Capital Holdings's Pfizer position peaked at $9.54M in Q4 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Freestone Capital Holdings's 13F filing for Q1 2026, filed 13 May 2026.